Dapagliflozin 10 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FL81C
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,920
Award facts
- Contract value 100% obligated
- $13,920.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30, with a contract ceiling value of $13,920.00 and a firm fixed price structure. This award represents a competitive procurement with no set-aside designation and is expected to be completed by September 29, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply a broad range of pharmaceutical products, medical devices, and healthcare commodities across multiple therapeutic domains. This specific delivery order for the diabetes medication Dapagliflozin supports the Defense Logistics Agency's medical supply chain operations and contributes to healthcare support for defense and military personnel. The company's competitively awarded contracts and significant indefinite delivery vehicle position it as a qualified supplier capable of meeting federal pharmaceutical procurement requirements on an ongoing basis.
Quick answers
Who was awarded contract SPE2DB25FL81C?
SPE2DB25FL81C was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FL81C worth?
The government has obligated $13,920 on SPE2DB25FL81C.
Is contract SPE2DB25FL81C an order under another contract?
Yes. SPE2DB25FL81C is a delivery order under SPE2DB20D2002, an indefinite delivery contract.
Was contract SPE2DB25FL81C competed?
The extent of competition for SPE2DB25FL81C was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award